These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 17200834

  • 1. Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients.
    Arbouw ME, Movig KL, Neef C, Guchelaar HJ, Egberts TC.
    Eur J Clin Pharmacol; 2007 Feb; 63(2):181-7. PubMed ID: 17200834
    [Abstract] [Full Text] [Related]

  • 2. Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa.
    van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A.
    Br J Clin Pharmacol; 2002 Aug; 54(2):168-70. PubMed ID: 12207636
    [Abstract] [Full Text] [Related]

  • 3. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures.
    Ziere G, Dieleman JP, van der Cammen TJ, Hofman A, Pols HA, Stricker BH.
    J Clin Psychopharmacol; 2008 Aug; 28(4):411-7. PubMed ID: 18626268
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Influence of benzodiazepines on antiparkinsonian drug treatment in levodopa users.
    van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A.
    Acta Neurol Scand; 2002 Jan; 105(1):8-12. PubMed ID: 11903102
    [Abstract] [Full Text] [Related]

  • 8. Current approaches to management of depression in Parkinson's Disease.
    Vajda FJ, Solinas C.
    J Clin Neurosci; 2005 Sep; 12(7):739-43. PubMed ID: 16026985
    [Abstract] [Full Text] [Related]

  • 9. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles MP, Geddes JR, Hardy R, Lewis G, Mason JM.
    Cochrane Database Syst Rev; 2007 Jul 18; (3):CD002791. PubMed ID: 17636706
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The Use of Antidepressive Agents and Bone Mineral Density in Women: A Meta-Analysis.
    Schweiger JU, Schweiger U, Hüppe M, Kahl KG, Greggersen W, Jauch-Chara K, Fassbinder E.
    Int J Environ Res Public Health; 2018 Jun 30; 15(7):. PubMed ID: 29966324
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Retrospective study of selegiline-antidepressant drug interactions and a review of the literature.
    Ritter JL, Alexander B.
    Ann Clin Psychiatry; 1997 Mar 30; 9(1):7-13. PubMed ID: 9167831
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.
    Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles MP, Geddes JR, Hardy R, Lewis G, Mason JM.
    Cochrane Database Syst Rev; 2000 Mar 30; (4):CD002791. PubMed ID: 11034764
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Weight outcomes among antidepressant users in nursing facilities.
    Rigler SK, Webb MJ, Redford L, Brown EF, Zhou J, Wallace D.
    J Am Geriatr Soc; 2001 Jan 30; 49(1):49-55. PubMed ID: 11207842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.